Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (26) 26
science & technology (26) 26
female (20) 20
humans (20) 20
male (20) 20
hematology (18) 18
transplantation (18) 18
middle aged (14) 14
stem cells (14) 14
adult (12) 12
immunology (12) 12
hematology, oncology and palliative medicine (10) 10
aged (9) 9
hematopoietic stem cells (9) 9
busulfan (8) 8
oncology (7) 7
retrospective studies (7) 7
treatment outcome (7) 7
survival analysis (6) 6
biological and medical sciences (5) 5
care and treatment (5) 5
fludarabine (5) 5
hematopoietic stem cell transplantation - methods (5) 5
infant (5) 5
infant, newborn (5) 5
leukemia, myeloid, acute - pathology (5) 5
leukemia, myeloid, acute - therapy (5) 5
medical sciences (5) 5
pediatrics (5) 5
recurrence (5) 5
remission induction (5) 5
vidarabine - analogs & derivatives (5) 5
abridged index medicus (4) 4
acute myeloid leukemia (4) 4
adolescent (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biophysics (4) 4
child (4) 4
diseases (4) 4
dosage and administration (4) 4
leukemia (4) 4
leukemia, myeloid, acute - mortality (4) 4
myelodysplastic syndromes - mortality (4) 4
myelodysplastic syndromes - therapy (4) 4
prognosis (4) 4
relapse (4) 4
stem cell transplantation (4) 4
transplantation, homologous (4) 4
young adult (4) 4
allogeneic stem cell transplantation (3) 3
antineoplastic agents (3) 3
azacitidine - analogs & derivatives (3) 3
babies (3) 3
busulfan - administration & dosage (3) 3
children (3) 3
cyclophosphamide (3) 3
drug therapy (3) 3
graft vs host disease - mortality (3) 3
graft-versus-host reaction (3) 3
hematopoietic stem cell transplantation (3) 3
hemic and lymphatic diseases (3) 3
infants (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
mortality (3) 3
patient outcomes (3) 3
patients (3) 3
premature birth (3) 3
survival (3) 3
time factors (3) 3
transplantation conditioning - methods (3) 3
united states (3) 3
usage (3) 3
vidarabine - therapeutic use (3) 3
acute disease (2) 2
age factors (2) 2
aged patients (2) 2
aged, 80 and over (2) 2
allergy (2) 2
aml (2) 2
antimitotic agents (2) 2
asthma (2) 2
azacitidine - administration & dosage (2) 2
busulfan - pharmacokinetics (2) 2
busulfan - therapeutic use (2) 2
cancer (2) 2
child, preschool (2) 2
chimerism (2) 2
clinical trials (2) 2
clofarabine (2) 2
cohort studies (2) 2
conditioning (2) 2
conditioning regimen (2) 2
cytogenetics (2) 2
databases, factual (2) 2
drugstores (2) 2
general aspects (2) 2
graft survival (2) 2
graft vs host disease - drug therapy (2) 2
graft vs host disease - etiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Viral Reactivation in Haploidentical Transplants Using Post-Transplantation Cyclophosphamide – a Single Institution Experience
by Ramlal, Reshma, MD and Sasaki, Koji, MD and Cerrada, Sara Lozano, MD and Srour, Samer A., MD and Chen, Julianne, BS and Rondon, R. Gabriella, MD and Rezvani, Katy, MD and Oran, Betul, MD and Olson, Amanda, M.D and Shpall, Elizabeth J., MD and Champlin, Richard E., MD and Ciurea, Stefan O., MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S375 - S376
Hematology, Oncology and Palliative Medicine | Cyclophosphamide | Transplantation | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Myeloablative Timed Sequential Busulfan Is Safe in Patients with Relapsed or High-Risk Multiple Myeloma
by Qazilbash, Muzaffar H., MD and Chen, Julianne, BS and Valdez, Ben C., PhD and Sasaki, Koji, MD and Kawedia, Jitesh D., RPh, PhD and Bashir, Qaiser, MD and Hosing, Chitra, MD and Kebriaei, Partow, MD and Nieto, Yago, MD, PhD and Shah, Nina, MD and Patel, Krina, MD and Shpall, Elizabeth J., MD and Andersson, Borje S., MD, PhD and Champlin, Richard E., MD and Popat, Uday R., MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S228 - S229
Hematology, Oncology and Palliative Medicine | Care and treatment | Relapse | Pharmacy | Multiple myeloma | Stem cells | Drugstores | Transplantation | Busulfan | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Myeloablative Timed Sequential Busulfan is Safe and Appears Promising in Older Patients with AML/MDS
by Popat, Uday R., MD and Lyons, Genevieve and Bassett, Roland, MS and Chen, Julianne, BS and Valdez, Ben C., PhD and Kawedia, Jitesh D., RPh, PhD and Ahmed, Sairah, MD and Alousi, Amin M., MD and Anderlini, Paolo, MD and Bashier, Qaiser and Ciurea, Stefan O., MD and Hosing, Chitra, MD and Jones, Roy B., MD, PhD and Kebriaei, Partow, MD and Khouri, Issa F., MD and Marin, David and Nieto, Yago, MD, PhD and Olson, Amanda, M.D and Oran, Betul, MD and Parmar, Simrit, MD and Patel, Krina, MD and Qazilbash, Muzaffar H., MD and Rezvani, Katy, MD and Shah, Nina, MD and Shpall, Elizabeth J., MD and Andersson, Borje S., MD, PhD and Champlin, Richard E., MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. S33 - S34
Hematology, Oncology and Palliative Medicine | Drugstores | Aged patients | Transplantation | Busulfan | Pharmacy | Stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children
by Guilbert, Theresa W and Bacharier, Leonard B and Mauger, David T and Phipatanakul, Wanda and Szefler, Stanley J and Boehmer, Susan and Beigelman, Avraham and Fitzpatrick, Anne M and Jackson, Daniel J and Baxi, Sachin N and Benson, Mindy and Burnham, Carey-Ann D and Cabana, Michael D and Castro, Mario and Chmiel, James F and Covar, Ronina and Daines, Michael and Gaffin, Jonathan M and Gentile, Deborah A and Holguin, Fernando and Israel, Elliot and Kelly, H. William and Lazarus, Stephen C and Lemanske, Robert F and Ly, Ngoc and Meade, Kelley and Morgan, Wayne and Moy, James and Olin, J. Tod and Peters, Stephen P and Pongracic, Jacqueline A and Raissy, Hengameh H and Ross, Kristie and Sheehan, William J and Sorkness, Christine and Teague, W. Gerald and Thyne, Shannon and Martinez, Fernando D and Bartnikas, Lisa and Bouzaher, Alisha and Burke, Christopher and Cavanaugh, Matthew and Chen, Julia and Cunningham, Elizabeth and Cunningham, Amparito and Friedlander, James and Hindi, Enal and Kantor, David and Permaul, Perdita and Rao, Devako and Rossi, Melinda and Schierembergg, Doris and Schneider, Kynda and Troung, Jennifer and Umetsu, Dale and Zhou, Joseph and Chmielewski, Jill and Fishbein, Anna and Flexas, Iliana and Fuleihan, Ramsay and Kumar, Rajesh and Lane, James and Makhija, Melanie and Martos, Louis and Parker, Brandon and Prince, Benjamin and Qamar, Nashmia and Riordan, Mary and Robinson, Rachel and Samady, Waheeda and Szychlinski, Christine and Tsang, Daniel and Codispoti, Christopher and Fu, Juan and Li, Grace and Munoz-Mendoza, Diana and Thompson, Benjamin and Gleason, Melanie and Graves, Sakari and Malka, Jonathan and Phillips, Melanie and Spears, Gayle and Sundstrom, D and White, Michael and Batson, Christina and Davies, Lea and Kelly, Franceska and Morales, Esmeralda and Redway, Abby and Spicher, Mary and Kaminski, Lauren and Knutson, Megan R and Miller, Kelly and Promer, Jennifer and Turcsanyi, Sheila and Watson, Tanya and Aujla, Shean and Broyles, John and Chong, Hey and Dubin, Patricia and ... and National Heart, Lung, and Blood Institute's AsthmaNet and Natl Heart Lung Blood Inst
Journal of allergy and clinical immunology, ISSN 0091-6749, 05/2019, Volume 143, Issue 5, pp. 1934 - 1937.e4
Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Corticoids | Health care | Pediatrics | Parents | Colleges & universities | Immunoglobulin E | Wheezing | Blood | Education | Facsimile communication | Race | Children | Rainbows | Emergency medical services | Public health | Medical personnel | Spears | Phenotypes | Corticosteroids | Enrollments | Hypersensitivity | Feasibility studies | Health care facilities | Minority & ethnic groups | Children & youth | Asthma | Medicine | Babies | Preschool children | Informed consent | Rosemary | Skin | Skin tests | Index Medicus | Abridged Index Medicus | Preschool Wheezing | Lower respiratory tract infections | Preschool-aged Children | oral corticosteroids | efficacy | multi-center clinical trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Minimal Residual Disease By PCR Testing Is a Significant Predictor of Disease Relapse in Patients with FLT3 Positive AML after Hematopoietic Stem Cell Transplantation
by Gaballa, Sameh, MD and Saliba, Rima, PhD and Oran, Betul, MD and Brammer, Jonathan E., MD and Chen, Julianne, BS and Rondon, Gabriela, MD and Alousi, Amin M., MD and Kebriaei, Partow, MD and Popat, Uday R., MD and Andersson, Borje S., MD, PhD and Shpall, Elizabeth J., MD and Jabbour, Elias, MD and Daver, Naval, MD and Andreeff, Michael and Ravandi, Farhad, MD and Cortes, Jorge, MD and Champlin, Richard E., MD and Ciurea, Stefan O., MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. S81 - S82
Hematology, Oncology and Palliative Medicine | Care and treatment | Relapse | Leukemia | Stem cells | Medical tests | Transplantation | Hematopoietic stem cells | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cytogenetics and Blast Count Determine Transplant Outcomes in Advanced AML
by Popat, Uday R., MD and Saliba, Rima, PhD and Oran, Betul, MD and Chen, Julianne, BS and Alousi, Amin M., MD and Ahmed, Sairah and Bashir, Qaiser, MD and Ciurea, Stefan O., MD and Hosing, Chitra, MD and Jones, Roy B., MD, PhD and Kebriaei, Partow, MD and Khouri, Issa F., MD and Nieto, Yago L., MD, PhD and Olson, Amanda, M.D and Parmar, Simrit, MD and Shah, Nina, MD and Shpall, Elizabeth J., MD and Qazilbash, Muzaffar H., MD and Andersson, Borje S., MD, PhD and Champlin, Richard E., MD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 2, pp. S304 - S304
Hematology, Oncology and Palliative Medicine | Cytogenetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS
by Alatrash, Gheath and Kidwell, Kelly M and Thall, Peter F and Di Stasi, Antonio and Chen, Julianne and Zope, Madhushree and Crain, Alyssa K and Champlin, Richard E and Popat, Uday and Shpall, Elizabeth J and Jones, Roy B and Andersson, Borje S
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 2018, Volume 54, Issue 8, pp. 1245 - 1253
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Treatment outcome | Usage | Analysis | Stem cells | Dosage and administration | Busulfan | Graft-versus-host reaction | Intravenous administration | Transplants & implants | Toxicity | Myeloid leukemia | Leukemia | Stem cell transplantation | Survival | Myelodysplastic syndrome | Fludarabine | Chimerism | Conditioning | Acute myeloid leukemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
by Andersson, B.S and Thall, P.F and Valdez, B.C and Milton, D.R and Al-Atrash, G and Chen, J and Gulbis, A and Chu, D and Martinez, C and Parmar, S and Popat, U and Nieto, Y and Kebriaei, P and Alousi, A and De Lima, M and Rondon, G and Meng, Q.H and Myers, A and Kawedia, J and Worth, L.L and Fernandez-Vina, M and Madden, T and Shpall, E.J and Jones, R.B and Champlin, R.E
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 04/2017, Volume 52, Issue 4, pp. 580 - 587
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Recurrence | Humans | Middle Aged | Male | Drug Monitoring - methods | Hematopoietic Stem Cell Transplantation - mortality | Busulfan - administration & dosage | Transplantation Conditioning - mortality | Transplantation, Homologous - mortality | Myelodysplastic Syndromes - therapy | Adult | Female | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Busulfan - pharmacokinetics | Treatment Outcome | Vidarabine - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - toxicity | Busulfan - toxicity | Leukemia, Myeloid, Acute - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Myelodysplastic Syndromes - mortality | Survival Analysis | Vidarabine - administration & dosage | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Homologous - methods | Usage | Dosage and administration | Fludarabine | Busulfan | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)
by Beumer, Jan H and Owzar, Kouros and Lewis, Lionel D and Jiang, Chen and Holleran, Julianne L and Christner, Susan M and Blum, William and Devine, Steven and Kolitz, Jonathan E and Linker, Charles and Vij, Ravi and Alyea, Edwin P and Larson, Richard A and Ratain, Mark J and Egorin, Merrill J
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 11/2014, Volume 74, Issue 5, pp. 927 - 938
Medicine & Public Health | Oncology | Cancer Research | Bone marrow transplant | Busulfan | Pharmacology/Toxicology | Pharmacokinetics | Elderly | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Busulfan - blood | Acute Disease | Age Factors | Busulfan - pharmacokinetics | Area Under Curve | Humans | Middle Aged | Male | Metabolic Clearance Rate | Myeloablative Agonists - pharmacokinetics | Myeloablative Agonists - blood | Leukemia, Myeloid - metabolism | Female | Aged | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid - therapy | Antimitotic agents | Medical research | Analysis | Leukemia | Mortality | Medicine, Experimental | Transplantation | Hematopoietic stem cells | Index Medicus | busulfan | pharmacokinetics | bone marrow transplant | elderly
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once Daily IV Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
by Alatrash, Gheath, DO, PhD and Thall, Peter F., PhD and Valdez, Benigno C., PhD and Fox, Patricia S., MSc and Ning, Jing, PhD and Garber, Haven R., MD and Janbey, Selma and Worth, Laura L., MD and Popat, Uday, MD and Hosing, Chitra, MD and Alousi, Amin M., MD and Kebriaei, Partow, MD and Shpall, Elizabeth J., MD and Jones, Roy B., MD, PhD and de Lima, Marcos, MD and Rondon, Gabriela, MD and Chen, Julianne, BS and Champlin, Richard E., MD and Andersson, Borje S., MD, PhD
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1792 - 1800
Hematology, Oncology and Palliative Medicine | Conditioning regimen | Clofarabine | Allogeneic Stem Cell Transplantation | Fludarabine | Busulfan
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib
by Sharma, Manish and Ravandi, Farhad and Bayraktar, Ulas Darda and Chiattone, Alexandre and Bashir, Qaiser and Giralt, Sergio and Chen, Julianne and Qazilbash, Muzaffar and Kebriaei, Partow and Konopleva, Marina and Andreeff, Michael and Cortes, Jorge and McCue, Deborah and Kantarjian, Hagop and Champlin, Richard E and de Lima, Marcos
Biology of blood and marrow transplantation, ISSN 1083-8791, 2011, Volume 17, Issue 12, pp. 1874 - 1877
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | FLT3 | Acute myeloid leukemia | Sorafenib | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Niacinamide - analogs & derivatives | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | fms-Like Tyrosine Kinase 3 - biosynthesis | Recurrence | Prognosis | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Leukemia, Myeloid, Acute - enzymology | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Leukemia, Myeloid, Acute - surgery | Retrospective Studies | Pyridines - therapeutic use | Pyridines - administration & dosage | Combined Modality Therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Hematopoietic Stem Cell Transplantation - methods | Leukemia, Myeloid, Acute - genetics | Transplantation, Homologous - methods | Tyrosine | Relapse | Care and treatment | Genes | Antineoplastic agents | Hematopoietic stem cells | Diseases | Antimitotic agents | Chemotherapy | Stem cells | Bone marrow | Phosphotransferases | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes
by Lee, Hans C and Saliba, Rima M and Rondon, Gabriela and Chen, Julianne and Charafeddine, Yasmeen and Medeiros, L. Jeffrey and Alatrash, Gheath and Andersson, Borje S and Popat, Uday and Kebriaei, Partow and Ciurea, Stefan and Oran, Betul and Shpall, Elizabeth and Champlin, Richard
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1948 - 1954
Hematology, Oncology and Palliative Medicine | Relapse | Chimerism | Acute myeloid leukemia | Myelodysplastic syndrome | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Myeloablative Agonists - therapeutic use | Recurrence | Prognosis | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Myelodysplastic Syndromes - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Busulfan - therapeutic use | Leukemia, Myeloid, Acute - pathology | Hematopoietic Stem Cell Transplantation | Graft Survival | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Remission Induction | Transplantation Chimera | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Myelodysplastic Syndromes - mortality | Survival Analysis | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Transplantation Conditioning | Myelodysplastic Syndromes - pathology | Myelodysplastic Syndromes - immunology | Analysis | Stem cells | Development and progression | T cells | Hematopoietic stem cells | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Ex Vivo T Cell–Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission
by Bayraktar, Ulas D and de Lima, Marcos and Saliba, Rima M and Maloy, Molly and Castro-Malaspina, Hugo R and Chen, Julianne and Rondon, Gabriela and Chiattone, Alexander and Jakubowski, Ann A and Boulad, Farid and Kernan, Nancy A and O'Reilly, Richard J and Champlin, Richard E and Giralt, Sergio and Andersson, Borje S and Papadopoulos, Esperanza B
Biology of blood and marrow transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 6, pp. 898 - 903
Hematology, Oncology and Palliative Medicine | AML | Stem cell transplantation | Transplant outcomes | T cell depletion | GVHD | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Graft vs Host Disease - therapy | Recurrence | Thiotepa - administration & dosage | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Lymphocyte Depletion | Antilymphocyte Serum - administration & dosage | Busulfan - administration & dosage | Graft vs Host Disease - immunology | Transplantation, Homologous | Graft vs Host Disease - mortality | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | T-Lymphocytes - pathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Vidarabine - analogs & derivatives | Remission Induction | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Melphalan - administration & dosage | Survival Analysis | T-Lymphocytes - immunology | Aged | Vidarabine - administration & dosage | Medical colleges | Cyclophosphamide | Histocompatibility antigens | Tacrolimus | HLA histocompatibility antigens | Homografts | Stem cells | Lectins | Methotrexate | T cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights